These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 328781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA, Lucas ZJ.
    J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
    Haskill JS, Fett JW.
    J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
    [Abstract] [Full Text] [Related]

  • 7. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF, Parks WP, Lopez DM.
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG, Good RA.
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract] [Full Text] [Related]

  • 10. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
    Huber SA, Lucas ZJ.
    J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
    [No Abstract] [Full Text] [Related]

  • 11. Tumor-bound immunoglobulins: their possible role in circumventing antitumor immunity.
    Witz IP, Levy HJ, Keisari Y, Izsak FC.
    Johns Hopkins Med J Suppl; 1974 Dec; 3():289-300. PubMed ID: 4214276
    [No Abstract] [Full Text] [Related]

  • 12. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS, Radov LA, Yamamura Y, Parthenais E, Korn JH, Ritter FL.
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract] [Full Text] [Related]

  • 13. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
    Bertini M, Forni G, Comoglio PM.
    Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
    [Abstract] [Full Text] [Related]

  • 14. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC, Miller FR, Heppner GH.
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA, Bigi G, Lucas ZJ.
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [Abstract] [Full Text] [Related]

  • 18. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B.
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract] [Full Text] [Related]

  • 19. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
    Werkmeister JA, Burns GF, Triglia T.
    J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.